Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients

被引：0
|
作者：
C Stephan
H Jaeger
A Carganico
G Knecht
T Lutz
C Mayr
FA Mosthaf
S Koeppe
M Mueller
E Wolf
A Tappe
E Wellmann
H Knechten
机构：
[1] Klinikum der Johann-Wolfgang-Goethe-Universität,MVZ Karlsplatz
[2] HIV Research and Clinical Care Centre,undefined
[3] Praxis Dres. S. Dupke/A. Carganico/A. Baumgarten,undefined
[4] Infektiologikum Frankfurt,undefined
[5] MVZ-Aerzteforum Seestrasse,undefined
[6] Praxis Dres. F. A. Mosthaf/M. Procaccianti/K. Zutavern-Bechtold,undefined
[7] Praxis Dres. S. Koeppe/P. Kreckel,undefined
[8] Praxis Dres. B. Frietsch/A. Ulmer/M. Mueller,undefined
[9] MUC Research,undefined
[10] Roche Pharma AG,undefined
[11] Praxenzentrum Blondelstrasse (PZB),undefined
来源：
European Journal of Medical Research | / 15卷
关键词：
HIV; protease inhibitor; saquinavir; cholesterol; triglycerides;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Short-term safety and tolerability of switch of backbone antiretroviral agents to coformulated tenofovir disoproxil fumarate/emtricitabine in HIV-positive Taiwanese patients
    Chang, Hsi-Yen
    Wu, Pei-Ying
    Zhang, Jun-Yu
    Yang, Shang-Ping
    Luo, Yu-Zhen
    Liu, Wen-Chun
    Sun, Hsin-Yun
    Hung, Chien-Ching
    Chang, Shan-Chwen
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [32] Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
    Thomas-Geevarghese, A
    Raghavan, S
    Minolfo, R
    Holleran, S
    Ramakrishnan, R
    Ormsby, B
    Karmally, W
    Ginsberg, HN
    El-Sadr, WM
    Albu, J
    Berglund, L
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (01): : 146 - 154
  • [33] A Longitudinal Study of the Changes in Body Fat and Metabolic Parameters in a South African Population of HIV-Positive Patients Receiving an Antiretroviral Therapeutic Regimen Containing Stavudine
    George, Jaya A.
    Venter, Willem D. F.
    Van Deventer, Hendrick E.
    Crowther, Nigel J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (08) : 771 - 781
  • [34] Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor - Containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir
    Abgrall, Sophie
    Yeni, Patrick G.
    Bouchaud, Olivier
    Costagliola, Dominique
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (01) : 120 - 127
  • [35] Rifabutin for treating tuberculosis in HIV infected adult patients receiving a boosted protease inhibitor containing antiretroviral regimen: experiences of neutropenia from an urban clinic
    Mudzviti, Tinashe
    Shamu, Tinei
    Chimbetete, Cleophas
    Maponga, Charles
    Morse, Gene
    PHARMACOTHERAPY, 2015, 35 (11): : E211 - E211
  • [36] Increased adiposity with initiation of protease-inhibitor-only antiretroviral therapy is associated with improved insulin sensitivity in HIV-positive subjects
    Maughan, R. T.
    Feeney, E. R.
    Capel, E.
    Capeau, J.
    Domingo, P.
    Villarroya, F.
    Lange, J. M. A.
    Phanuphak, P.
    Cooper, D. A.
    Reiss, P.
    Mallon, P. W. G.
    ANTIVIRAL THERAPY, 2014, 19 : A25 - A26
  • [37] Efficacy and safety of anti-tuberculosis drugs in HIV-positive patients: A prospective study
    Kapadia, Jigar D.
    Desai, Chetna K.
    Solanki, Manish N.
    Shah, Asha N.
    Dikshit, R. K.
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 (05) : 447 - 452
  • [38] SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
    Campo, R.
    DeJesus, E.
    Bredeek, U. F.
    Henry, K.
    Khanlou, H.
    Logue, K.
    Brinson, C.
    Benson, P.
    Dau, L.
    Wang, H.
    White, K.
    Flaherty, J.
    Fralich, T.
    Guyer, B.
    Piontkowsky, D.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1637 - 1645
  • [39] Treatment of HIV-positive patients with lamivudine plus boosted protease inhibitor in a real-world setting
    Cheng, Chien-Yu
    Cheng, Shu-Hsing
    Chang, Shu-Yin
    Lin, Mei-Hui
    Ku, Shin-Yen
    Shieh, Hui-Ting
    Sun, Na-Lee
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [40] Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
    Restelli, Umberto
    Andreoni, Massimo
    Antinori, Andrea
    Bonfanti, Marzia
    Di Perri, Giovanni
    Galli, Massimo
    Lazzarin, Adriano
    Rizzardini, Giuliano
    Croce, Davide
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 409 - 414
12345